Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeMedia CenterPress releases FinancialJohnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

      Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

      Share Article
      share to

      New Brunswick, N.J., May 8th, 2024 Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine and John Reed, Executive Vice President, Innovative Medicine R&D will represent the Company in a session scheduled at 2:00 pm (Eastern Time).

      This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      The audio webcast replay will be available approximately 48-hrs after the webcast.

      Media contact:
      media-relations@its.jnj.com

      Investor contact:
      investor-relations@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.